Director Shelley G. Broader granted 3,562 RSUs at Inspire Medical (INSP)

Rhea-AI Filing Summary

Inspire Medical Systems director Shelley G. Broader received an equity grant of 3,562 Restricted Stock Units (RSUs) on common stock, with no cash paid per unit. After this award, her direct holdings total 8,471 common shares. Each RSU converts into one share if it vests.

The RSUs vest on the earlier of the first anniversary of the grant date or immediately before a qualifying Change of Control under the company’s 2018 Incentive Award Plan, assuming Broader continues to serve the company through the applicable vesting date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Broader Shelley G

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,562	$0.00	--

Holdings After Transaction: Common Stock — 8,471 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 3,562 shares Shares held after grant: 8,471 shares Grant price per share: $0.0000 per share +1 more

4 metrics

RSUs granted 3,562 shares Equity award reported on April 30, 2026

Shares held after grant 8,471 shares Total direct common stock holdings after transaction

Grant price per share $0.0000 per share Reported value for RSU award (compensation grant, not market buy)

RSU vesting timing Earlier of 1 year or Change of Control Vesting schedule under 2018 Incentive Award Plan

Key Terms

Restricted Stock Units ("RSUs"), Change of Control, 2018 Incentive Award Plan

3 terms

Restricted Stock Units ("RSUs") financial

"Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Change of Control financial

"the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan)"

A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.

2018 Incentive Award Plan financial

"Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued service"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Broader Shelley G

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MINNESOTA 55416

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/30/2026		A		3,562(1)	A	$0	8,471	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

	/s/ Bryan Phillips, Attorney-in-Fact for Shelley G. Broader	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Inspire Medical Systems (INSP) report for Shelley G. Broader?

Inspire Medical Systems reported that director Shelley G. Broader received a grant of 3,562 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of common stock if vesting conditions tied to time or Change of Control are satisfied.

How many Inspire Medical Systems (INSP) shares does Shelley G. Broader hold after this Form 4 transaction?

Following the RSU award, Shelley G. Broader holds 8,471 shares of Inspire Medical Systems common stock directly. This figure reflects her position after the 3,562-share equity grant reported in the Form 4 filing covering the April 30, 2026 award.

What are the vesting conditions for Shelley G. Broader’s new RSUs in Inspire Medical Systems (INSP)?

The RSUs vest on the earlier of the first anniversary of the grant date or immediately before a Change of Control as defined in Inspire Medical Systems’ 2018 Incentive Award Plan, provided Shelley G. Broader continues serving the company through the applicable vesting date.

Did Shelley G. Broader pay cash for the Inspire Medical Systems (INSP) RSU grant reported on Form 4?

No cash changed hands for this RSU grant. The Form 4 shows 3,562 shares of common stock awarded at a reported price of $0.0000 per share, indicating a compensation-related equity award rather than an open-market purchase transaction.

What does the Form 4 reveal about the type of transaction for Inspire Medical Systems (INSP)?

The Form 4 describes the transaction as a grant, award, or other acquisition of common stock through RSUs. It is categorized with transaction code “A,” reflecting a compensation-related equity award to director Shelley G. Broader rather than a market buy or sell.